Old and new anti-obesity drugs

被引：0
作者：
Dodangeh, Salimeh [1 ]
Hasani-Ranjbar, Shirin [2 ]
机构：
[1] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran
来源：
JOURNAL OF DIABETES AND METABOLIC DISORDERS | 2024年 / 24卷 / 01期
关键词：
Obesity; Overweight; Anti-obesity medication; Weight loss medication; GLUCAGON-LIKE PEPTIDE-1; GLP-1 RECEPTOR AGONIST; WEIGHT-LOSS; CLINICAL ENDOCRINOLOGISTS; APPETITE SUPPRESSION; AMERICAN ASSOCIATION; EXTENDED-RELEASE; GENE-EXPRESSION; OBESE-PATIENTS; DOUBLE-BLIND;
D O I：
10.1007/s40200-024-01512-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Obesity is a pandemic problem that correlates with a cluster of metabolic factors leading to poor cardiovascular outcomes, morbidity, and an increased risk of overall mortality. It is necessary to approach obesity with a comprehensive treatment plan, which may involve lifestyle modifications (diet, exercise, and behavioral therapy) and pharmacological interventions. This article provides an overview of the mechanisms of action, efficacy, and safety of available long-term anti-obesity drugs and introduces other potential agents under investigation.
引用
收藏
页数：13
相关论文
共 81 条
  • [61] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    [J]. MOLECULAR METABOLISM, 2019, 30 : 72 - 130
  • [62] Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
    Mueller, T. D.
    Clemmensen, C.
    Finan, B.
    DiMarchi, R. D.
    Tschoep, M. H.
    [J]. PHARMACOLOGICAL REVIEWS, 2018, 70 (04) : 712 - 746
  • [63] Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver
    Newsome, Philip N.
    Ambery, Phil
    [J]. JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1557 - 1565
  • [64] Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis
    Pan, Xin-Hui
    Tan, Bryan
    Chin, Yip Han
    Lee, Ethan Cheng Zhe
    Kong, Gwyneth
    Chong, Bryan
    Kueh, Martin
    Khoo, Chin Meng
    Mehta, Anurag
    Majety, Priyanka
    Grandhi, Gowtham R.
    Dimitriadis, Georgios K.
    Foo, Roger
    Chew, Nicholas W. S.
    Le Roux, Carel W.
    Mamas, Mamas A.
    Chan, Mark Y.
    [J]. OBESITY, 2024, 32 (05) : 840 - 856
  • [65] A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
    Pi-Sunyer, Xavier
    Astrup, Arne
    Fujioka, Ken
    Greenway, Frank
    Halpern, Alfredo
    Krempf, Michel
    Lau, David C. W.
    le Roux, Carel W.
    Violante Ortiz, Rafael
    Jensen, Christine Bjorn
    Wilding, John P. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01) : 11 - 22
  • [66] Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis
    Pradhan, Richeek
    Montastruc, Francois
    Rousseau, Vanessa
    Patorno, Elisabetta
    Azoulay, Laurent
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01) : 13 - 14
  • [67] Setmelanotide: A Novel Targeted Treatment for Monogenic Obesity
    Pressley, Haley
    Cornelio, Cyrille K.
    Adams, Erin N.
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (06) : 368 - 373
  • [68] Glucagon, from past to present: a century of intensive research and controversies
    Scheen, Andre J.
    Lefebvre, Pierre J.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (02) : 129 - 138
  • [69] The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
    Secher, Anna
    Jelsing, Jacob
    Baquero, Arian F.
    Hecksher-Sorensen, Jacob
    Cowley, Michael A.
    Dalboge, Louise S.
    Hansen, Gitte
    Grove, Kevin L.
    Pyke, Charles
    Raun, Kirsten
    Schaffer, Lauge
    Tang-Christensen, Mads
    Verma, Saurabh
    Witgen, Brent M.
    Vrang, Niels
    Knudsen, Lotte Bjerre
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10) : 4473 - 4488
  • [70] GIP and GLP-1, the two incretin hormones: Similarities and differences
    Seino, Yutaka
    Fukushima, Mitsuo
    Yabe, Daisuke
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (1-2): : 8 - 23
123456789